Oxford Biomedica Ownership
ISIN
GB00BDFBVT43
Symbol
OXB
Industry
Oxford Biomedica Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Briarwood Chase Management LLC
|
18.639m | 15.44% | — | Apr 15 2026 |
| 2 |
Novo Holdings A/S
|
13.458m | 11.15% | — | Apr 15 2026 |
| 3 |
Institut Merieux SA
|
13.019m | 10.78% | — | Apr 15 2026 |
| 4 |
M&G Investment Management Ltd.
|
5.694m | 4.72% | -38.000k | Apr 15 2026 |
| 5 |
Serum Life Sciences Ltd
|
3.771m | 3.12% | — | Apr 15 2026 |
|
1
Briarwood Chase Management LLC
|
15.44%
18.639m
|
|
2
Novo Holdings A/S
|
11.15%
13.458m
|
|
3
Institut Merieux SA
|
10.78%
13.019m
|
|
4
M&G Investment Management Ltd.
|
4.72%
5.694m
|
|
5
Serum Life Sciences Ltd
|
3.12%
3.771m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 45.20% of Oxford Biomedica, with Briarwood Chase Management LLC the biggest at 15.44%, followed by Novo Holdings A/S (11.15%) and Institut Merieux SA (10.78%). |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
